Smaart Pharmaceutticals is an API manufacturer. It holds 2 active US drug master files across a filed portfolio of 2 molecules. Customs aggregates show $677K of exports covering 75 molecules to 20 destinations in 2025.
| Molecule | Regulators | Docs |
|---|---|---|
| Chlorhexidine | US FDA | 1 |
| Nebivolol | US FDA | 1 |
Also appears on these molecule pages
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $238K | 11 |
| 2025 | Not reported | $677K | 20 |
| 2024 | Not reported | $524K | 18 |
| 2023 | Not reported | $811K | 21 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Smaart Pharmaceutticals comes back tiered against every other supplier able to file there.
Start for free